Back

Medical treatment implementation in ambulatory patients with HF: preliminary data from the nationwide BRING-UP3 HF study

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Diuretics and intravenous iron and more Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Emilia D'Elia

Papa Giovanni XXIII Hospital, Bergamo (Italy)

2 More presentations in this session

Presentation thumbnail
Effects of intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF): a comprehensive multicenter phase 2 randomized clinical trial
Mr S. Nassiri (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Withdrawal of neurohumoral blockade in patients with normalized ejection fractions after cardiac resynchronization therapy: long-term follow-up of the STOP-CRT trial
Doctor M. Van Es (Genk, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Diuretics and intravenous iron and more

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Discharge medical treatment implementation in patients admitted for AHF: preliminary data from the BRING-UP3 HF study
thumbnail
Congress Presentation
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience
thumbnail
Congress Presentation
Contemporary patient characterization and implementation of medical therapy for heart failure across the ejection fraction spectrum: the OPTIPHARM-HF registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources